← Back to Search

Home Blood Pressure Monitoring for High Blood Pressure Control in Stroke Patients

N/A
Recruiting
Led By Liron D Kraler, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant or surrogate able to apply a home blood pressure cuff on the participant
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 3 and 6
Awards & highlights

Study Summary

This trial aims to see if providing a free home blood pressure monitor can help control hypertension, especially for disadvantaged patients, and reduce negative health outcomes.

Who is the study for?
This trial is for adults over 18 who've been treated at Stanford Hospital's stroke service and are going home or to acute rehab. They must have had a stroke, mini-stroke, or be at risk of stroke with high blood pressure but don't own a blood pressure cuff. They can't join if they're in another similar study or have an upper arm larger than 20 inches.Check my eligibility
What is being tested?
The study tests if giving patients a free home blood pressure monitor and teaching them how to use it helps control high blood pressure better than just routine education. It also checks if this approach works well for disadvantaged groups and reduces negative health outcomes.See study design
What are the potential side effects?
Using the Omron Home Blood Pressure Cuff generally doesn’t cause side effects; however, incorrect use might lead to inaccurate readings which could affect treatment decisions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I or someone I trust can use a home blood pressure monitor on me.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 3 and 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 3 and 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood pressure
Secondary outcome measures
Any hospitalization
Incidence of TIA
Incidence of stroke

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Access to Blood Pressure MonitoringExperimental Treatment1 Intervention
Participants will also receive the teaching administered to the control group. In addition, they will be given an Omron Home Blood Pressure Cuff furnished by the study. The nurse will provide additional education on on how to use the cuff, and how to record values in a blood pressure log.
Group II: Standard of CareActive Control1 Intervention
Participants will receive routine stroke discharge education which is standard of care. A stroke nurse will provide and review with the patient a short informational pamphlet on the importance of blood pressure monitoring.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,300 Total Patients Enrolled
Liron D Kraler, MDPrincipal InvestigatorStanford University
Christina M Mijalski Sells, MDPrincipal InvestigatorStanford University

Media Library

Use of Omron Home Blood Pressure Cuff Clinical Trial Eligibility Overview. Trial Name: NCT05730465 — N/A
Vascular Disease Research Study Groups: Standard of Care, Access to Blood Pressure Monitoring
Vascular Disease Clinical Trial 2023: Use of Omron Home Blood Pressure Cuff Highlights & Side Effects. Trial Name: NCT05730465 — N/A
Use of Omron Home Blood Pressure Cuff 2023 Treatment Timeline for Medical Study. Trial Name: NCT05730465 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research team currently recruiting participants for this trial?

"Clinicaltrials.gov shows that this research endeavour, which was first made known on March 1st 2023 and had its most recent update two weeks later, is no longer recruiting patients to take part in the study. Nevertheless there are other trials still welcoming volunteers; 1848 of them at present."

Answered by AI
~22 spots leftby Jan 2025